Small Cell Lung Cancer
4 competing products in clinical development for Small Cell Lung Cancer.
Pipeline by Phase
Phase 11
Phase 1/21
Phase 22
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Prexasertib | Eli Lilly | Phase 2 | Completed | 52 |
| Pemetrexed | Eli Lilly | Phase 2 | Terminated | 52 |
| pemetrexed + cisplatin | Eli Lilly | Phase 1/2 | Terminated | 41 |
| LY3295668 Erbumine | Eli Lilly | Phase 1 | Completed | 33 |